Company Overview
| Stock Name | 盈健醫療集團有限公司 |
|---|---|
| Stock Code | 01419 |
| Company Full Name | 盈健醫療集團有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要在香港營運醫務中心。 |
| Listing Date | 2016-04-01 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港九龍九龍灣常悅道3號企業廣場2期12樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.humanhealth.com.hk |
| Share Registrar | |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 1.38 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 7.0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 52,909,200 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 1.99 |
|---|---|
| First Day Open | HK$ 1.85 |
| First Day Change | 44.20% |
| First Day Volume | 180834000.0 |
| First Day Turnover | 361008000.0 |
Use of Proceeds
| Use of Proceeds | 1、約31.5百萬港元（相當于所得款項凈額的46.0%）將用于為在香港透過設立六間新專科醫務中心以擴充本集團的醫務中心網絡提供部分資金； 2、約4.8百萬港元（相當于所得款項凈額的7.0%）將用于為在香港透過設立六間新全科醫務中心擴充本集團的醫務中心網絡提供部分資金； 3、約10.3百萬港元（相當于所得款項凈額的15.0%）將用于為本集團擴充至中國市場提供部分資金； 4、約6.9百萬港元（相當于所得款項凈額的10.0%）將用于在香港收購已設立的醫務中心； 5、約4.1百萬港元（相當于所得款項凈額的6.0%）將用于在香港透過聘請品牌顧問、進行品牌建設活動及翻新及維護我們現有醫務中心以提升我們的品牌形象； 6、約4.1百萬港元（相當于所得款項凈額的6.0%）將用于提升我們的信息科技基建設施； 7、約6.9百萬港元（相當于所得款項凈額的10.0%）將用于營運資金及其他一般企業用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
BOCOM International (Asia) Limited CE API271
Overall Coordinators (1)
交银国际证券有限公司 CE APJ121
Joint Bookrunners (2)
交银国际证券有限公司 CE APJ121
首控证券有限公司
Joint Lead Managers (4)
交银国际证券有限公司 CE APJ121
首控证券有限公司
RHB SECURITIES HONG KONG LIMITED CE ADU220
EVERHOT SECURITIES LIMITED CE ABH246
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 首都医疗国际有限公司 | 34,011,480 HKD | — | 7.04% | — | 6 months | 2016-10-01 |
Directors & Management
| Chairman | 陳健平 |
|---|---|
| Company Secretary | 文靜欣 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 陳健平及家族成員(68.29%);首都醫療國際有限公司(68.29%) |
|---|
